|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C. |
| 公司地址
| 3891 Ranchero Drive, Suite 150, Ann Arbor, MI, USA, 48108 |
| 電話號碼
| +1 734 887-3903 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.esperion.com |
| 員工數量
| 304 |
| Mr. John B. Harlow, Jr |
Chief Commercial Officer |
-- |
04/11/2025 |
| Mr. Benjamin O. Looker |
General Counsel |
美元 471.00K |
17/04/2025 |
| Mr. Benjamin Halladay |
Chief Financial Officer and Principal Accounting Officer |
美元 467.33K |
17/04/2025 |
| Mr. Sheldon L. Koenig |
Director, President and Chief Executive Officer |
美元 745.83K |
04/11/2025 |
|
|
| Mr. Robert E. Hoffman, C.P.A. |
Independent Director |
01/04/2025 |
| Mr. Seth H.Z. Fischer |
Independent Director |
17/04/2025 |
| Dr. Craig B. Thompson,M.D. |
Independent Director |
01/07/2025 |
| Ms. Tracy M. Woody |
Independent Director |
17/04/2025 |
| Mr. J. Martin Carroll |
Chairman of the Board |
17/04/2025 |
| Mr. Jay P. Shepard |
Independent Director |
17/04/2025 |
| Mr. Stephen C. Rocamboli |
Independent Director |
17/04/2025 |
| Mr. Sheldon L. Koenig |
Director, President and Chief Executive Officer |
04/11/2025 |
|
|
|
|
